Thomas Hudson
Chief Tech/Sci/R&D Officer en ABBVIE INC. .
Fortuna: 20 M $ al 31/03/2024
Perfil
Fundador de la Universidad McGill y del Centro de Innovación Gnome Qubec, Thomas J. Hudson es director científico y vicepresidente senior de I+D de AbbVie, Inc. También es director científico del Consorcio P3G y profesor de la Universidad de Toronto. Anteriormente fue Presidente y Director Científico del Instituto de Investigación Oncológica de Ontario, Director Adjunto del Centro de Investigación Genómica del Instituto Whitehead de Investigación Biomédica y Director de la Universidad McGill y del Centro de Innovación Gnome Qubec.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ABBVIE, INC.
0.01% | 28/02/2024 | 107 267 ( 0.01% ) | 20 M $ | 31/03/2024 |
Cargos activos de Thomas Hudson
| Empresas | Cargo | Inicio |
|---|---|---|
| ABBVIE INC. | Chief Tech/Sci/R&D Officer | 01/07/2019 |
| University of Toronto | Corporate Officer/Principal | 01/01/2007 |
| P3G Consortium | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Thomas Hudson.
| Empresas | Cargo | Fin |
|---|---|---|
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | President | 01/01/2016 |
| McGill University & Génome Québec Innovation Centre | Founder | 01/01/2011 |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2001 |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Formación de Thomas Hudson.
| University of Montréal | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
| P3G Consortium |
- Bolsa de valores
- Insiders
- Thomas Hudson
